Abstract
Human-type lymphoid tissue organoids, which stably function in our body for a certain period of time or longer, may have a great potential as immune-stimulatory or immune-regulatory devices and could be utilized in the future for the treatment of various diseases such as cancer, severe infection, autoimmunity and congenital as well as acquired immunodeficiency resulting from severe infections or aging. In this review, we discuss about rationality and trials of the synthesis of immunologically functional lymphoid tissue organoids mainly in mouse. We have been recently trying to construct immunologically functioning human-type organoids, and the efforts are also briefly described.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ager A (2017) High Endothelial Venules and other blood vessels: critical regulators of lymphoid organ development and function. Front Immunol 8:45. https://doi.org/10.3389/fimmu.2017.00045
Bar-Ephraim YE, Konijn T, Gonuitas M, Mebius RE, Reijimers M (2016) A reproducible method for isolation and in vitro culture of functional human lymphoid stromal cells from tonsils. PLoS ONE 11(12)e0167555. https://doi.org/10.1371/journal.pone.0167555
Brahmer JR, Tykod SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 365:2455–2465. https://doi.org/10.1056/NEJMoa1200694
Brown CE, Allzadeh D, Starr R, Weng L, Wagner JR et al (2016) Regression of glioblastoma after chimeric antigen receptor T-cell therapy. New Engl J Med 375:2561–2016. https://doi.org/10.1056/NEJMoa1610497
Buckley CD, Barone F, Nayar S, Benezech C, Caamano L (2015) Stromal cells in chronic inflammation and tertiary lymphoid organ formation. Annu Rev Immunol 33:715–745. https://doi.org/10.1146/annrev-immunol-032713-120252
Carragher DM, Rangel-Moreno J, Randall TD (2008) Ectopic lymphoid tissues and local immunity. Semin Immunol 20:26–42. https://doi.org/10.1069/j-smim.2007.12.004
Chai Q, Onder L, Scandella E, Gil-Cruz C, Perez-Shibayama C, Cupovic J et al (2013) Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity 38:1013–1024. https://doi.org/10.1016/j.immuni.2013.03.012
Colbeck EJ, Ager A, Gallimore A, Jones GW (2017) Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or Bystander sentinels in diseases? Front Immunol 8:1830. https://doi.org/10.3389/fimmu.2017/01830
Couillault C, Germain C, Dubois B, Kaplon H (2018) Identification of tertiary lymphoid structure-associated follicular helper T cells in human tumors and tissues. Methods Mol Biol 1845:205–222. https://doi.org/10.1007/978-1-4939-8709-2_12
Crotty S (2011) Follicular helper CD4 T cells (T-FH). Annu Rev Immunol 29:621–663. https://doi.org/10.1146/annurev-immunol-031210-101400
Cupedo T, Stroock A, Coles M (2012) Application of tissue engineering to the immune system: development of artificial lymph nodes. Front Immunol 3:343. https://doi.org/10.3389/fimmu.2012.00343
de Leur K, Clahsen-van Groningen MC, van den Bosch TPP, der Graav GN, Hesselink DA, Samsom JN, Baan CC, Boer K (2018) Characterization of ectopic lymphoid structures in different types of acute renal allograft rejection. Clic Exp Immunol 192:224–232. https://doi.org/10.1111/cei.13099
Dieu-Nosjean MC, Goc J, Giraldo NA, Sautes-Fridman C, Fridman WH (2014) Tertiary lymphoid structures in cancer and beyond. Trends Immunol 35:571–580. https://doi.org/10.1016/j.it.2014.09.006
Dieu-Nosjean MC, Giraldo NA, Kaplon H, Germain C, Fridman WH, Sautes-Fridman C (2016) Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol Rev 271:260–275. https://doi.org/10.1111/imr.12405
Dorraji SE, Hovd A-MK, Kanapathippillai P, Bakland G, Eilertsen G, Figenschau SL, Fenton KA (2018) Mesenchymal stem cells and T cells in the formation of tertiary lymphoid structures in lupus nephritis. Sci Rep 8:7861. https://doi.org/10.1038/s41598-018-26265-z
Drayton DL, Liao S, Mounzer RH, Ruddle NH (2006) Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 7:344–353. https://doi.org/10.1038/ni1330
Engelhard VH, Rodriguez AB, Mauldin IS, Woods AN, Peske JD, Slingluff CL (2018) Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity. J Immunol 200:432–442. https://doi.org/10.4049/jimmunol.1701269
Eshhar Z, Waks T, Bendavid A, Schindler DG (2001) Functional expression of chimeric receptor genes in human T cells. J Immunol Methods 248:67–76. https://doi.org/10.1016/s0022-1759(00)00343-4
Fennema E1, Rivron N, Rouwkema J, van Blitterswijk C, de Boer J (2013) Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol 31:108–115. https://doi.org/10.1016/j.tibtech.2012.12.003
Figenschau SL, Fismen S. Fenton KA, Fenton C, Mortensen ES (2015) Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients. BMC Cancer (101). https://doi.org/10.1186/s12885-015-1116-1
Fletcher AL, Malhotra D, Acton SE, Lukacs-Kornek V, Bellemare-Pelletier A, Curry M et al (2011) Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells. Front Immunol 2:35. https://doi.org/10.3389/fimmu.2011.00035
Fonseca VR, Romao VC, Aqua-Doca A, Santos M, Lopez-Presa D, Ferreira AC, Fonseca JE, Graca L (2018) The ratio of blood T follicular regulatory cells to T follicular helper cells marks ectopic lymphoid structure formation while activated follicular helper T cells indicate disease activity in primary Sjogren syndrome. Arthritis Rheumatol 70:774–784. https://doi.org/10.1002/art.40424
Fu YX, Chaplin DD (1999) Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 17:399–433. https://doi.org/10.1146/annurev.Immunol.17.1.399
Gommerman JL, Browning JL (2003) Lymphotoxin/LIGHT, lymphoid microenvironments and disease. Nat Rev Immunol 3:642–655. https://doi.org/10.1038/nri1151
Grabner R, Lotzer K, Dopping S, Hildner M, Radke D, Beer M et al (2009) Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med 206:233–248. https://doi.org/10.1084/jem.20080752
Halle S, Dujardin HC, Bakocevic N, Fleige H, Danzer H, Willenzon S, Suezer Y, Hammerling G, Garbi N, Sutter N, Worbs T, Forster R (2009) Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J Exp Med 206:2593–2601. https://doi.org/10.1084/jem.20091472
Hiraoka N, Ino Y, Yamazaki-Itoh R (2016) Tertiary lymphoid organs in cancer tissues. Front Immunol 7:244. eCollection 2016 https://doi.org/10.3389/fimmu.2016.00244
Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P et al (2015) Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular Smooth muscle cell lymphotoxin beta Receptors. Immunity 42:1100–1115. https://doi.org/10.1016/j.immuni.2015.05.015
Hughes CE, Benson RA, Bedaj M, Maffia P (2016) Antigen-presenting cells and antigen presentation in tertiary lymphoid organs. Front Immunol 7:481. eCollection 2016. https://doi.org/10.3389/fimmu.2016.00481
Johansson-Percival A et al (2015) Intratumoral LIGHT restores pericyte contractile properties and vessel integrity. Cell Rep 13:2687–2698. https://doi.org/10.1016/j.celrep.2015.12.004
Johansson-Percival A, He B, Li ZJ, Kjellen A, Russel K, Li Ji, Larma I, Ganss R (2017) De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat Immunol 18:1207–1217. https://doi.org/10.1038/ni.3836
Johasson A, Hamzah J, Ganss R (2016) More than a scaffold: stromal modification of tumor immunity. Biochim Biophys Acta 1865:3–13. https://doi.org/10.1016/j.bbcan.2015.06.001
Jones GW, Jones SA (2016) Ectopic lymphoid follicles: inducible centers for generating antigen-specific immune responses within tissues. Immunology 147:141–151. https://doi.org/10.1111/imm.12554
Jones E, Gallimore A, Ager A (2018) Defining high endothelial venules and tertiary lymphoid structures in cancer. Methods Mol Biol 1845:99–118. https://doi.org/10.1007/978-1-4939-8709-2_7
Joyce JA, Fearon DT (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348:74–80. https://doi.org/10.1126/science.aaas6204
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH (2011) T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 3(95):95ra73. https://doi.org/10.1126/scitransmed.300284
Kashima S, Kawamoto H, et al (2020) Cytotoxic T lymphocytes regenerated from iPS cells have therapeutic efficiency in a patient-derived xenograft solid tumor model. iScience 23:100998. https://doi.org/1.1016/j.isci.2020.100998
Kawamoto H, Masuda K, Nagao S, Maeda T (2018) Cloning and expansion of antigen-specific T cells using iPS cell technology: development of “off-the-shelf” T cells for the use in allogeneic transfusion settings. Int J Hematol 107:271–277. https://doi.org/10.1007/s12185-018-2399-1
Kobayashi Y, Watanabe T (2010) Synthesis of artificial lymphoid tissue with immunological function. Trends Immunol 31:422–428. https://doi.org/10.1016/j.it.2010.09.002
Kobayashi Y, Watanabe T (2016) Gel-trapped lymph-organogenic chemokines trigger artificial tertiary lymphoid organs and mount adaptive immune responses in vivo. Front Immunol 7:316. https://doi.org/10.3389/fimmu.2016.00316
Kobayashi Y, Kato K, Watanabe T (2011) Synthesis of functional artificial lymphoid tissues. Discov Med 12:351–362 PMID:22031672
Kobayashi S, Murata K, Shibuya H, Morita M, Ishikawa M, Furu M et al (2013) A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium. Arthritis Rheum 65:3063–3072. https://doi.org/10.1002/art.38173
Kobayashi Y, Kato K, Nakamura M, Watanabe T (2016) Synthresis of functional tertiary lymphoid organs. In: Watanabe T, Takahama Y (eds) Synthetic immunology. Springer Nature, pp 151–169. https://doi.org/10.1007/978-4-431-56027-2_7
Koning JJ, Mebius RE (2012) Interdependence of stromal and immune cells for lymph node function. Trends Immunol 33:264–270. https://doi.org/10.1016/j.it.2011.10.006
Kroeger DR, Milne K, Nelson BH (2016) Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer. Clin Cancer Res 22:3005–3015. https://doi.org/10.1158/1078-0432.CCR-15-2762
Kuwabara S, Tsuchikawa T, Nalamura T, Hatanaka Y, Hatanaka K, Sasaki K, Ono M, Umemoto K, Suzuki T, Sato O, Hane Y, Nakanishi Y, Asano T, Ebihara Y, Kurashima Y, Noji T, Murakami S, Okamura K, Shichinohe T, Hirano S (2019) Prognostic relevance of tertiary organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Cancer Sci 110:1853–1862. https://doi.org/10.1111/cas.14023
Lenti E, Brendolan A, et al (2019) Therapeutic regeneration of lymphatic and immune cell function upon lympho organoid transplantation. Stem Cell Reports 12:1260-1268. https://doi.org/10.1016/j.stemcr.2019/04.021
Lin L1, Hu X1, Zhang H1, Hu H1 (2019) Tertiary lymphoid organs in cancer immunology: mechanisms and the new strategy for immunotherapy. Front Immunol 10:1398. https://doi.org/10.3389/fimmu.2019.0139887
Loeffler M, Le’nergrate G, Krajewska M, Reel JC (2007) Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. Proc Nat Acad Sci USA 104:12879–12883. https://doi.org/10.1073/pnas.0701959104
Lotzer K, Dopping S, Connert S, Grabner R, Spanbroek R, Lemser B et al (2010) Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling. Arterioscler Thromb Vasc Biol 30:395–402. https://doi.org/10.1161/ATVBAHA.109.191395
Lukashev M, Lepage D, Wilson C, Bally V, Garber E, Lukashin A et al (2006) Targeting the lymphotoxin-(beta) receptor with agonist antibodies as a potential cancer therapy. Cancer Res 66:9617–9624. https://doi.org/10.1158/0008-5472.CAN-06-0217
Maher J, Brentjens RJ, Gunset G, Riviere I, Sadelain M (2002) Human T-lymphocye cytotoxicity and proliferation directed by a single chimeric TCRzeta/CD28 receptor. Nat Biotechnol 20:70–75. https://doi.org/10.1038/nbt0102-70
Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM et al (2014) Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 371:1507–1517. https://doi.org/10.1056/nejmoa1407222
Mebius RE (2003) Organogenesis of lymphoid tissues. Nat Rev Immunol 63:292–303. https://doi.org/10.1038/nri1054
Nasr IW, Reel M, Oberbarnscheidt MH, Mounzer RH, Baddoura FK, Ruddle NH et al (2007) Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am J Transplant 7:1071–1079. https://doi.org/10.1111/j.1600-6143.2007.01756.x
Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN (2012) Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol 33:297–305. https://doi.org/10.1016/j.it.2012.04.006
Okamoto N, Chihara R, Shimizu C, Nishimoto S, Watanabe T (2007) Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. J Clin Invest 117:997–1007. https://doi.org/10.1172/jci30379
Randall TD, Carragher DM, Rangel-Moreno J (2008) Development of secondary lymphoid organs. Annu Rev Immunol 26:627–650. https://doi.org/10.1146/annurev.immunol.26.021607.090257
Roco JA, Mesin L, Binder CB, Nefzger C, Gonzalez-Figueroa P, Canete PF, Ellyard J, Shen Q, Robert PA, Cappelo J, Vohra H, Zhang Y, Nowosad CR, Schiepers A, Corcoran LM, Toellner K-M, Polo JM, Meyer-Hermann M, Victora GD, Vinuesa CG (2019) Class-switch recombination occurs infrequently in germinal centers. Immunity 51:337–350. https://doi.org/10.1016/j.immuni.2019.07.001
Roozendaal R, Mebius RE (2011) Stromal cell-immune cell interactions. Annu Rev Immunol 29:23–437. https://doi.org/10.1146/annurev-immunol-031210-101357
Rosenberg SA, Dudley ME (1990) Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 21:233–240. https://doi.org/10.1016/j.coi2009.03.002
Ruddle NH (2014) Lymphatic vessels and tertiary lymphoid organs. J Clin Invest 124:953–959. https://doi.org/10.1172/JCI71611
Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren- Herlenius M et al (2003) Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren’s syndrome. Arthritis Rheum 48:3187–3201. https://doi.org/10.1002/art.11311
Sautes-Fridman C, Petitprez F, Calderaro J, Fridman WH (2019) Tertiary lymphoid structures in the era of cancer immunotherapy. Nature Rev Cancer 19:307–325. https://doi.org/10.1038/s41568-019-0144-6
Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K (2002) Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxinbeta in mesenteric lymph node genesis. J Exp Med 195:1613–1624. https://doi.org/10.1084/jem.20020215
Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE et al (2001) Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol 166:650–655. https://doi.org/10.4049/jimmunol.166.1.650
Sicard A, Chen CC, Morelon E, Thaunat O (2016) Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection. Curr Opin Organ Transplant 21:368–373. https://doi.org/10.1097/MOT.0000000000000329
Silina K, Burkhardt C, Casanova R, Solterman A, van den Broek M (2018) A quatitative pathology approach to analyze the development of human cancer-associated tertiary lymphoid structures. Methods Mol Biol 1845:71–86. https://doi.org/10.1007/978-1-4939-8709-2_5
Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, Bisso P, Rodrigues-Vitoria J, Richard F, Migllori E, Noel G, Duvillier H, Craclun L, Vevs I, Awada A, Detours V, Larsimont D, Piccart-Gebhart M, Willard-Gallo K (2017) Immune checkpoint molecules on tumor-infiltrating lymphocytes and their association with tertiary lymphoid structures in human breast cancer. Front Immunol 8:1412. https://doi.org/10.3389/fimmu.2017.01412
Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C (1998) Antigen driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren’s syndrome. J Clin Invest 102:938–946. https://doi.org/10.1172/jci3234
Suematsu S, Watanabe T (2004) Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol 22:1539–1545. https://doi.org/10.1038/nbt1039
Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O’Fallon WM, Goronzy JJ, Weyand CM (2001) Lymphoid neogenesis in rheumatoid synovitis. J. Immunol 167:1072–1080. https://doi.org/10.4049/jimmunol.167.2.1072
Tan JKH, Watanabe T (2014) Murine spleen tissue regeneration from neonatal spleen capsulerequires lymphotoxin priming of stromal cells. J Immunol 193:1194–1203. https://doi.org/10.4049/jimmunol.1302115
Tan JKH, Watanabe T (2017) Stromal cell subsets directing neonatal spleen regeneration. Sci Rep 7:40401. https://doi.org/10.1038/srep40401
Tang H, Wang Y, Chlewicki LK, Zhang Y, Guo J, Liang W, Wang J, Wang X, Fu YX (2016) Facilitating T cell infiltration in tumor microenvironment overcomes resistance to PD-L1 blockade. Cancer Cell 29:285–296. https://doi.org/10.1016/j.ccell.2016.02.004
Thaunat O, Graff-Dubois S, Brouard S, Gautreau C, Varthaman A, Fabien N et al (2010a) Immune responses elicited in tertiary lymphoid tissues display distinctive features. PLoS ONE 30:e11398. https://doi.org/10.1371/journal.pone.0011398
Thaunat O, Patey N, Caligiuri G, Gautreau C, Mamani-Matsuda M, Mekki Y et al (2010b) Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol 185:717–728. https://doi.org/10.4049/jimmunol.0903589
Thomas JA, Willcox HN, Newsom-Davis J (1982) Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses. J Neuroimmunol 3:319–335. https://doi.org/10.1016/0165-5728(82)90035-2
Topalian SL, Hod FS, Brahmer JR, Gettinger SN, Smith DC et al (2012) Safety, activity, and immune correlates of anti-PD1 antibody in cancer. N Engl J Med 366:2443–2454. https://doi.org/10.1056/NEJMoa1200690
Tschenig T, Pabst R, Prenzier F, Rittinghausen S, Braun A, Hohlfeld JM (2018) Isolated aggregates of lymphoid cells in the inner bronchial wall in asthma patients. Cell Tissue Res 374:423–425. https://doi.org/10.1007/s00441-018-2936-5
Turley SJ, Cremasco V, Astarita JL (2015) Immunological hallmarks of stromal cells in the tumor microenvironment. Nature Rev Immunol 15:669–682. https://doi.org/10.1038/nri.3902
Wang PL, Zhu M, Miller M, Fu YX (2009) Immunoregulation by tumor necrosis factor superfamily member LIGHT. Immunol Rev 229:232–243. https://doi.org/10.1111/j.1600-065X.2009.00762,x
Weinstein AM, Girald NA, Petitprez F, Julie C, Lacroix L, Peschaud F, Emile JF, Marisa L, Fridman WH, Storkus WJ, Sautes-Fridman C (2019) Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer. Cancer Immunol Immunother 68:109–120. https://doi.org/10.1007/s00262-018-2259-0
Weiss JM, Cufi P, Le Panse R, Berrih-Aknin S (2013) The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ. Rev Neurol (Paris) 169:640–649. https://doi.org/10.1016/j.neurol.2013.02.005
Yin C, Mohanta S, Maffla P, Habenicht AJR (2017) Editorial: tertiary lymphoid organs (TLOs): powerhouses of disease immunity. Front Immunol 8(228). https://doi.org/10.3389/fimmu.2017.00228
Young CL, Adamson TC, 3rd, Vaughan JK, Fox RI (1984) Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum 27: 32–39. https://doi.org/10.1002/art.1780270106
Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX (2004) Priming of naïve T cells inside tumors leads to eradication of established tumors. Nat Immunol 5:141–149. https://doi.org/10.1038/ni1029
Yu P, Lee Y, Wang Y, Liu X, Auh S, Gajeski TF, Schreiber H, You AZ, Kayor C, Wang X, Fu XY (2007) Targeing the primary tumors to generate CTL for the effective eradication of spontaneous metastasis. J Immunol 179:1960–1968. https://doi.org/10.4049/jimmunol.179.3.1960
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kobayashi, Y., Watanabe, T. (2020). Artificial Construction of Immune Tissues/Organoids and Their Application for Immunological Intervention. In: Kabashima, K., Egawa, G. (eds) Inducible Lymphoid Organs. Current Topics in Microbiology and Immunology, vol 426. Springer, Cham. https://doi.org/10.1007/82_2020_215
Download citation
DOI: https://doi.org/10.1007/82_2020_215
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51746-5
Online ISBN: 978-3-030-51747-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)